Sept 20 (Reuters) - The U.S. Food and Drug
Administration approved Zevra Therapeutics' ( ZVRA ) drug for a
rare and fatal genetic disorder, the first treatment to get a
nod for the condition, the health regulator said on Friday.
(Reporting by Sriparna Roy and Kashish Tandon in Bengaluru;
Editing by Devika Syamnath)